Reliance-Owned Netmeds Losses Swell Up In FY20; Revenue Falls 44%

[What The Financials] Reliance-Acquired Netmeds Losses Balloon After 44% Lower Revenue In FY20

SUMMARY

Even though Netmeds managed to curb its spending in the year, it did not manage to grow the income commensurately

The company saw its total income for the year fall by a whopping 44% with income from operations seeing a massive slide of nearly 75%

In August 2020, Reliance Retail acquired a majority stake in Netmeds in a deal worth $83 Mn

Infocus

What The Financials

Inc42 unveils and deciphers all the important financial metrics of Indian startups across industries. Find out revenues, unit economics, profit & loss and all the important financial metrics to judge how the startup will perform in the coming years.

Netmeds Marketplace, the B2C ecommerce unit of online pharmacy Netmeds, saw its total income decline by 44% to INR 7.7 Cr in FY20 from INR 13.93 Cr in the fiscal year 2018-19 (FY19). The company had a negative net worth of INR 14.2 Cr as per its latest financial filings and a net profit margin of -2,111%.

Even though Netmeds managed to curb its spending in the year, it did not manage to grow the income commensurately. The company’s expenses declined by 9% to INR 172 Cr in FY20 from INR 188 Cr in FY19. This resulted in a huge net loss of INR 164 Cr in the fiscal year ended March 31, 2020.

While its EBITDA improved slightly during the period under review, the company’s employee benefits expenses increased by 38%, from INR 23.19 Cr in FY19 to INR 31.90 Cr in FY20. However, other expenses, which includes the rent, fuel, conveyance, legal, advertising and other miscellaneous expenses, fell by 16%, from INR 161 Cr in FY19 to INR 135 Cr in FY20.

The company’s filings mention that it wasn’t impacted by the countrywide lockdown imposed from late-March till late-May last year to contain the spread of the Covid-19 pandemic. This was because, with physical distancing protocols in place, people relied on home delivery of medicines.

“With more people switching to online purchase of medicine, the sales since April 2020 have seen a positive trend. The company being in the essential services segment has not experienced any significant disruptions affecting its business,” the filings said about the FY21 performance.

RECOMMENDED FOR yOU

News

Meta Appointed As The Co-Chair Of USIBC’s AI Task Force

News

Third Wave Coffee’s FY23 Loss Nearly Quadruples To INR 55 Cr...

News

Gaming Startup WinZO’s FY23 Revenue Surges Nearly 3X To INR ...

Worryingly, revenue from operations fell drastically by nearly 75% from INR 19.6 Cr to INR 5 Cr in the year before Reliance acquired the company a few months into FY21. In August 2020, Reliance Retail entered the online pharmacy space by acquiring a majority stake NetMeds and its subsidiaries, formally known as Vitalic Health Private Limited, for INR 620 Cr ($83 Mn).

Netmeds marketplace, its holding company Tresara, and other subsidiaries Dadha Pharma Distribution Private Limited which deals with wholesale of medicines, together come under Vitalic, the parent company of Netmeds. Vitalic reported a consolidated turnover of INR 221.02 Cr and a net loss of INR 184.35 Cr in FY20.

Netmeds was founded in 2010 by Pradeep Dadha. The startup is a licensed pharmacy marketplace that offers authenticated prescription and over-the-counter (OTC) medicine digitally along with other health products. The company has acquired two healthtech startups KiViHealth and telemedicine startup JustDoc. As of March 2019, Netmeds claimed to have served more than 3.7 Mn customers in over 610 Indian cities and towns.

Reliance’s entry into the online pharmacy space has pitted the Indian MNC against ecommerce majors such as Amazon and Flipkart, also looking to tap into the segment. Meanwhile, to counter the bigger online pharmacies and giants entering the space, Medlife and Pharmacy merged last year to form a bigger entity with a unicorn valuation.

In September last year, Inc42 reported that 1mg could raise $100 Mn to take on ecommerce behemoths Amazon, Flipkart and Reliance.

According to an Inc42 Plus report titled, India’s Healthtech Landscape In A Post-Covid-19 World, the Indian healthtech market is projected to reach a market size of $21.3 Bn by 2025, from $5.2 Bn in 2019. The market is expected to grow at a CAGR (compound annual growth rate) of 27% between 2020-25 and will acquire 3.2% of the global healthtech market pie by the end of the period.

Within healthtech, online pharmacies have proven to be the most attractive bet for investors, having attracted funds worth $462 Mn between 2014-19, the most among the various sub-segments for India’s healthtech startups such as telemedicine and fitness and wellbeing, among others.